David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$570M |
| 2 |
Meta Platforms (Facebook)
META
|
+$469M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$342M |
| 4 |
Merck
MRK
|
+$322M |
| 5 |
MON
Monsanto Co
MON
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$434M |
| 2 |
Netflix
NFLX
|
+$301M |
| 3 |
Alibaba
BABA
|
+$245M |
| 4 |
Verizon
VZ
|
+$235M |
| 5 |
Tesla
TSLA
|
+$230M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.95% |
| 2 | Healthcare | 11.57% |
| 3 | Consumer Discretionary | 9.23% |
| 4 | Communication Services | 8.8% |
| 5 | Industrials | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
PUT
Silicon Laboratories
SLAB
$7.29B
| $1.84M | ﹤0.01% |
+20,900
| New | +$1.88M |
|
2152
Mueller Industries
MLI
$13.6B
| $1.84M | ﹤0.01% |
208,132
-197,424
| -49% | -$1.73M |
|
|
RDC
2153
PUT
DELISTED
Rowan Companies Plc
RDC
| $1.84M | ﹤0.01% |
117,500
-2,000
| -2% | -$28.1K |
|
2154
InterContinental Hotels
IHG
$24.1B
| $1.83M | ﹤0.01% |
27,403
+15,585
| +132% | +$940K |
|
2155
PUT
Halozyme
HALO
$12.4B
| $1.82M | ﹤0.01% |
+90,000
| New | +$1.65M |
|
|
TTM
2156
PUT
DELISTED
Tata Motors Limited
TTM
| $1.82M | ﹤0.01% |
55,100
+40,000
| +265% | +$1.29M |
|
2157
PennyMac Financial
PFSI
$3.85B
| $1.82M | ﹤0.01% |
81,435
+10,692
| +15% | +$211K |
|
2158
Quanex
NX
$916M
| $1.82M | ﹤0.01% |
77,727
-28,246
| -27% | -$626K |
|
2159
CALL
Adient
ADNT
$1.44B
| $1.82M | ﹤0.01% |
23,100
+3,100
| +16% | +$250K |
|
2160
PUT
Ingles Markets
IMKTA
$1.61B
| $1.82M | ﹤0.01% |
52,500
+3,000
| +6% | +$81.7K |
|
|
WRD
2161
DELISTED
WildHorse Resource Development
WRD
| $1.81M | ﹤0.01% |
98,566
-21,715
| -18% | -$326K |
|
2162
Intel
INTC
$462B
| $1.81M | ﹤0.01% |
39,249
-1,443,830
| -97% | -$63M |
|
2163
PUT
TAL Education Group
TAL
$6.43B
| $1.81M | ﹤0.01% |
61,000
-36,800
| -38% | -$1.12M |
|
2164
Ezcorp Inc
EZPW
$2.16B
| $1.81M | ﹤0.01% |
148,235
+39,573
| +36% | +$432K |
|
|
PDCE
2165
CALL
DELISTED
PDC Energy, Inc.
PDCE
| $1.8M | ﹤0.01% |
35,000
+200
| +0.6% | +$9.47K |
|
2166
MBIA
MBI
$250M
| $1.8M | ﹤0.01% |
+246,281
| New | +$1.92M |
|
2167
Carpenter Technology
CRS
$24.1B
| $1.8M | ﹤0.01% |
35,290
+419
| +1% | +$20.8K |
|
2168
PUT
Gartner
IT
$12.4B
| $1.8M | ﹤0.01% |
14,600
| – | – |
|
|
SODA
2169
DELISTED
SodaStream International Ltd
SODA
| $1.79M | ﹤0.01% |
25,514
-11,438
| -31% | -$757K |
|
2170
Regional Management Corp
RM
$308M
| $1.79M | ﹤0.01% |
68,185
-3,931
| -5% | -$96.2K |
|
|
ALXN
2171
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
| $1.79M | ﹤0.01% |
+15,000
| New | +$1.83M |
|
2172
The Ensign Group
ENSG
$10.4B
| $1.79M | ﹤0.01% |
86,298
+63,894
| +285% | +$1.37M |
|
|
LPNT
2173
DELISTED
LifePoint Health, Inc.
LPNT
| $1.79M | ﹤0.01% |
35,926
-13,605
| -27% | -$676K |
|
|
LHO
2174
DELISTED
LaSalle Hotel Properties
LHO
| $1.79M | ﹤0.01% |
63,651
-25,091
| -28% | -$719K |
|
2175
PUT
BioMarin Pharmaceuticals
BMRN
$12.8B
| $1.78M | ﹤0.01% |
20,000
| – | – |
|
Similar funds
David Shaw's Q4 2017 Portfolio in Review
As of Q4 2017, David Shaw held 3,940 positions worth $72.6B, up 12% from $65.1B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw deployed $3.73B of net new capital in Q4 2017, opening 507 new positions and adding to 1,441 existing holdings. Its largest new stake was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $434M trimmed.
- David Shaw's largest Q4 2017 buy was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
- David Shaw added most to GE Aerospace in Q4 2017, an estimated $570M increase.
- David Shaw's biggest Q4 2017 reduction was Apple, cutting an estimated $434M.
- David Shaw fully exited Tesla in Q4 2017, selling an estimated $230M.
- David Shaw's ten largest holdings make up 9.5% of its $72.6B portfolio in Q4 2017.
- David Shaw opened 507 new positions and closed 394 in Q4 2017.
- David Shaw's portfolio value rose 12% quarter-over-quarter to $72.6B.
Based on D.E. Shaw & Co's 13F filing for Q4 2017, filed 14 Feb 2018.